ECO ANIMAL HEALTH GROUP PLC

Report Publication Announcement • Sep 2, 2022

National Storage Mechanism | Additional information

RNS Number : 9602X

Eco Animal Health Group PLC

02 September 2022

2 September 2022

ECO Animal Health Group plc (the "Company")

(AIM: EAH)

Annual Report and Accounts & Annual General Meeting

ECO Animal Health Group plc announces the publication of the following documents ("the Documents") on the Company's website: www.ecoanimalhealthgroupplc.com/investor-relations.aspx.

·     Annual Report and Accounts for the year ended 31 March 2022

·    Notice of Annual General Meeting to be held at The Grange, 100 High Street, London, N14 6BN on 26 September 2022 at 11.30am ("AGM") and Form of Proxy

The Documents will be posted today to those shareholders that have elected to receive them by post.

For further information please contact:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
IFC Advisory Graham Herring Zach Cohen	020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas	020 7496 3000
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi Peel Hunt LLP (Joint Broker) Dr Christopher Golden James Steel	020 7597 5970 020 7418 8900

Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSZZGGLGMNGZZM